DK2099780T3 - 2-alkyl-indazol forbindelser til behandling af visse CNS-relaterede lidelser - Google Patents
2-alkyl-indazol forbindelser til behandling af visse CNS-relaterede lidelserInfo
- Publication number
- DK2099780T3 DK2099780T3 DK07846673.7T DK07846673T DK2099780T3 DK 2099780 T3 DK2099780 T3 DK 2099780T3 DK 07846673 T DK07846673 T DK 07846673T DK 2099780 T3 DK2099780 T3 DK 2099780T3
- Authority
- DK
- Denmark
- Prior art keywords
- alkyl
- treatment
- related disorders
- indazole compounds
- certain cns
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Anesthesiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT002230A ITMI20062230A1 (it) | 2006-11-22 | 2006-11-22 | Composto 2-alchil-indazolico procedimento per preparalo e composizione farmaceutica che lo comprende |
PCT/EP2007/010000 WO2008061688A1 (en) | 2006-11-22 | 2007-11-19 | 2 -alkyl- indazole compounds for the treatment of certain cns-related disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2099780T3 true DK2099780T3 (da) | 2013-04-15 |
Family
ID=38474157
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK07846673.7T DK2099780T3 (da) | 2006-11-22 | 2007-11-19 | 2-alkyl-indazol forbindelser til behandling af visse CNS-relaterede lidelser |
Country Status (23)
Country | Link |
---|---|
US (1) | US8507528B2 (es) |
EP (1) | EP2099780B1 (es) |
JP (1) | JP5551443B2 (es) |
KR (1) | KR101471987B1 (es) |
CN (1) | CN101558057B (es) |
AR (1) | AR063881A1 (es) |
AU (1) | AU2007323368B2 (es) |
BR (1) | BRPI0718976A2 (es) |
CA (1) | CA2668205C (es) |
DK (1) | DK2099780T3 (es) |
EA (1) | EA019217B1 (es) |
ES (1) | ES2401199T3 (es) |
GE (1) | GEP20125414B (es) |
HK (1) | HK1129112A1 (es) |
IL (1) | IL198432A (es) |
IT (1) | ITMI20062230A1 (es) |
MX (1) | MX2009005250A (es) |
PL (1) | PL2099780T3 (es) |
PT (1) | PT2099780E (es) |
SG (1) | SG176504A1 (es) |
SI (1) | SI2099780T1 (es) |
UA (1) | UA98311C2 (es) |
WO (1) | WO2008061688A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2012011231A (es) | 2010-04-08 | 2012-11-12 | Acraf | Compuesto de indazol triciclico, metodo de preparacion y composicion farmaceutica que lo contiene. |
AU2012230503B2 (en) | 2011-03-18 | 2016-07-07 | Bayer Intellectual Property Gmbh | N-(3-carbamoylphenyl)-1H-pyrazole-5-carboxamide derivatives and the use thereof for controlling animal pests |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS57501378A (es) * | 1980-09-05 | 1982-08-05 | ||
DE3687080T2 (de) * | 1985-04-27 | 1993-03-25 | Beecham Group Plc | Azabicyclononyl-indazol-carboxamid mit 5-ht-antagonistischer wirkung. |
GB8623142D0 (en) * | 1986-09-26 | 1986-10-29 | Beecham Group Plc | Compounds |
JPH02215779A (ja) * | 1989-02-14 | 1990-08-28 | Kuraray Co Ltd | カルボン酸アミド誘導体類及びその医薬用途 |
US5246947A (en) * | 1991-09-23 | 1993-09-21 | Hoechst-Roussel Pharmaceuticals Incorporated | Substituted pyridinylamino-1,2-benzisothiazoles and their use for treating depression |
AU4949293A (en) | 1992-08-28 | 1994-03-29 | Ciba-Geigy Ag | Indazole derivatives |
JPH08277287A (ja) * | 1995-02-09 | 1996-10-22 | Mitsubishi Chem Corp | インダゾール類およびその用途 |
CA2222532A1 (en) * | 1995-05-31 | 1996-12-05 | Nisshin Flour Milling Co., Ltd. | Indazole derivatives having monocyclic amine |
IT1291569B1 (it) * | 1997-04-15 | 1999-01-11 | Angelini Ricerche Spa | Indazolammidi come agenti serotoninergici |
US6069152A (en) * | 1997-10-07 | 2000-05-30 | Eli Lilly And Company | 5-HT4 agonists and antagonists |
US6218390B1 (en) * | 1998-12-17 | 2001-04-17 | Synaptic Pharmaceutical Corporation | Morpholinone and morpholine derivatives and uses thereof |
CN100439341C (zh) | 2002-12-02 | 2008-12-03 | 弗·哈夫曼-拉罗切有限公司 | 作为促肾上腺皮质激素释放因子拮抗剂的吲唑衍生物 |
ITMI20030972A1 (it) | 2003-05-15 | 2004-11-16 | Acraf | Indazolo dotato di attivita' analgesica, metodo per prepararlo e composizione farmaceutica che lo comprende. |
ITMI20031468A1 (it) | 2003-07-18 | 2005-01-19 | Acraf | Farmaco ativo nel dolore neuropatico |
FR2857966A1 (fr) * | 2003-07-24 | 2005-01-28 | Aventis Pharma Sa | Produits aryl-heteroaromatiques, compositions les contenant et utilisation |
ATE457309T1 (de) * | 2003-12-23 | 2010-02-15 | Serodus As | Modulatoren von peripheren 5-ht-rezeptoren |
BRPI0418351A (pt) * | 2004-01-05 | 2007-05-08 | Astrazeneca Ab | composto ou um sal farmaceuticamente aceitável do mesmo, métodos de limitar a proliferação celular em um humano ou animal, de tratamento de um humano ou animal sofrendo de cáncer, de tratamento de profilaxia de cáncer, de tratamento de um humano ou animal sofrendo de uma doença neoplásica, de tratamento de um humano ou animal sofrendo de uma doença prolifetativa de tratamento de cáncer, para o tratamento de infecções associadas com cáncer, para o tratamento profilático de infecções associadas com cáncer, composição farmacêutica, uso de um composto ou um sal farmaceuticamente aceitável do mesmo, método de inibir a chk1 quinase, e, processo para a preparação de um composto ou um sal farmaceuticamente aceitável do mesmo |
AU2005271737A1 (en) * | 2004-08-03 | 2006-02-16 | Wyeth | Indazoles useful in treating cardiovascular diseases |
TW200621237A (en) * | 2004-11-01 | 2006-07-01 | Wyeth Corp | [(1-h-indazol-3-yl)methyl]phenols and (hydroxyphenyl)(1h-indazol-3-yl)methanones |
PE20061130A1 (es) * | 2004-11-19 | 2007-01-05 | Arena Pharm Inc | Derivados de 3-fenil-pirazol como moduladores del receptor de serotonina 5-ht2a |
WO2008054748A2 (en) * | 2006-10-31 | 2008-05-08 | Arena Pharmaceuticals, Inc. | Indazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
-
2006
- 2006-11-22 IT IT002230A patent/ITMI20062230A1/it unknown
-
2007
- 2007-11-19 CA CA2668205A patent/CA2668205C/en not_active Expired - Fee Related
- 2007-11-19 JP JP2009537521A patent/JP5551443B2/ja not_active Expired - Fee Related
- 2007-11-19 EP EP07846673A patent/EP2099780B1/en active Active
- 2007-11-19 SG SG2011085891A patent/SG176504A1/en unknown
- 2007-11-19 ES ES07846673T patent/ES2401199T3/es active Active
- 2007-11-19 PL PL07846673T patent/PL2099780T3/pl unknown
- 2007-11-19 SI SI200731154T patent/SI2099780T1/sl unknown
- 2007-11-19 AU AU2007323368A patent/AU2007323368B2/en not_active Ceased
- 2007-11-19 DK DK07846673.7T patent/DK2099780T3/da active
- 2007-11-19 WO PCT/EP2007/010000 patent/WO2008061688A1/en active Application Filing
- 2007-11-19 MX MX2009005250A patent/MX2009005250A/es active IP Right Grant
- 2007-11-19 US US12/516,091 patent/US8507528B2/en not_active Expired - Fee Related
- 2007-11-19 UA UAA200905092A patent/UA98311C2/ru unknown
- 2007-11-19 GE GEAP200711320A patent/GEP20125414B/en unknown
- 2007-11-19 BR BRPI0718976-1A patent/BRPI0718976A2/pt not_active Application Discontinuation
- 2007-11-19 EA EA200970496A patent/EA019217B1/ru not_active IP Right Cessation
- 2007-11-19 CN CN2007800433966A patent/CN101558057B/zh not_active Expired - Fee Related
- 2007-11-19 KR KR1020097012960A patent/KR101471987B1/ko not_active IP Right Cessation
- 2007-11-19 PT PT78466737T patent/PT2099780E/pt unknown
- 2007-11-21 AR ARP070105165A patent/AR063881A1/es not_active Application Discontinuation
-
2009
- 2009-04-28 IL IL198432A patent/IL198432A/en active IP Right Grant
- 2009-09-25 HK HK09108893.2A patent/HK1129112A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR101471987B1 (ko) | 2014-12-12 |
SI2099780T1 (sl) | 2013-03-29 |
KR20090089880A (ko) | 2009-08-24 |
WO2008061688A1 (en) | 2008-05-29 |
CA2668205A1 (en) | 2008-05-29 |
AU2007323368A1 (en) | 2008-05-29 |
HK1129112A1 (en) | 2009-11-20 |
PT2099780E (pt) | 2013-03-11 |
MX2009005250A (es) | 2009-05-28 |
BRPI0718976A2 (pt) | 2014-02-04 |
ES2401199T3 (es) | 2013-04-17 |
ITMI20062230A1 (it) | 2008-05-23 |
JP2010510265A (ja) | 2010-04-02 |
JP5551443B2 (ja) | 2014-07-16 |
EP2099780A1 (en) | 2009-09-16 |
US20100056573A1 (en) | 2010-03-04 |
IL198432A (en) | 2013-03-24 |
GEP20125414B (en) | 2012-03-12 |
US8507528B2 (en) | 2013-08-13 |
PL2099780T3 (pl) | 2013-05-31 |
UA98311C2 (ru) | 2012-05-10 |
CN101558057A (zh) | 2009-10-14 |
SG176504A1 (en) | 2011-12-29 |
EA200970496A1 (ru) | 2009-10-30 |
EA019217B1 (ru) | 2014-02-28 |
AU2007323368B2 (en) | 2013-02-07 |
IL198432A0 (en) | 2010-02-17 |
CN101558057B (zh) | 2013-05-01 |
AR063881A1 (es) | 2009-02-25 |
EP2099780B1 (en) | 2013-01-09 |
CA2668205C (en) | 2014-10-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK2114886T3 (da) | Fremgangsmåde til fremstilling af visse substituerede sulfiliminer | |
DK2019683T4 (da) | Indgivelse af vækstfaktorer til behandling af CNS-lidelser | |
DK2474321T3 (da) | Sammensætninger til behandling af collagenmedierede sygdomme | |
DK1874781T3 (da) | Dihydrothienopyrimidiner til behandling af inflammatoriske sygdomme | |
DK3456707T3 (da) | 4-(p-quinonyl)-2-hydroxybutanamidderivater til behandling af mitokondriesygdomme | |
BRPI0918527A2 (pt) | compostos para o tratamento de disturbios do cns | |
DK2504005T3 (da) | Anvendelse af 1,3-diphenylprop-2-en-1-on-derivater til behandling af lever-sygdomme | |
DK2044026T3 (da) | Fremgangsmde til behandling af cerebral glioma tumor | |
DK3289876T3 (da) | Forbindelser til behandling af cancer | |
DK2478907T3 (da) | Sammensætninger til behandling af kræft | |
SMAP200900085A (it) | 3-imidazolil-indoli per il trattamento di malattieproliferative | |
DK2431359T3 (da) | Fremgangsmåde til fremstilling af diaminophenothiaziniumforbindelser | |
DK2959894T3 (da) | S1p-receptormodulatorer til behandling af multipel sklerose | |
DK3192520T3 (da) | Terapeutiske midler til reducering af niveauerne af parathyreoideahormon | |
DK3354276T3 (da) | Sammensætninger til behandlingen af gastrointestinal inflammation | |
DK1928438T3 (da) | Anvendelse af ibudilast til behandling af stofafhængighed | |
ZA200806074B (en) | Compounds for the treatment of inflammatory disorders | |
DK2285808T3 (da) | Spiroindolderivater til behandling af parasitsygdomme | |
DK2440230T3 (da) | Behandlingsregimener til behandling af neurologisk sygdom | |
DK2056842T3 (da) | Modificeret galactosylceramid til behandling af cancerøse sygdomme | |
DK2209784T3 (da) | Forbindelser til behandling af hepatitis C | |
DK2117525T3 (da) | Anvendelse af 1-phenyl-3-dimethylamino-propanforbindelser til behandling af neuropatismerte | |
DK2010184T3 (da) | Implatanter til behandlingen af dopamin associerede tilstande | |
DK2117565T3 (da) | Anvendelse af chitosaner til behandlingen af negleinflammatoriske sygdomme | |
DK1841433T3 (da) | Præparat til behandling af lidelser i centralnervesystemet |